Eribulin mesylate: For
the treatment of patients with locally advanced
or metastatic breast cancer who have progressed after at least two
chemotherapeutic regimens for advanced
disease. Prior therapy should have included an anthracycline and a taxane
unless patients were not suitable for these treatments
Degarelix: For the treatment of adult patients with advanced
hormone dependent prostate cancer
Source: CDSCO
No comments:
Post a Comment